Bovax Biotechnology
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A vaccine specialist developing and manufacturing prophylactic biologics for human and animal health.
Infectious DiseaseAnimal Health
Technology Platform
Utilizes multiple vaccine technology platforms including traditional inactivated/live-attenuated methods and modern recombinant protein production.
Opportunities
Growing demand for vaccines in emerging markets and potential for technology licensing from global innovators.
Risk Factors
Intense price competition and regulatory hurdles for new vaccine approvals in international markets.
Competitive Landscape
Competes in the crowded vaccine market but is strengthened by domestic manufacturing mandates and government partnerships.